Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma.


Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
11 2019
Historique:
received: 09 01 2019
accepted: 07 05 2019
revised: 06 05 2019
pubmed: 16 6 2019
medline: 15 7 2020
entrez: 16 6 2019
Statut: ppublish

Résumé

In 2008, Feng et al. identified Merkel cell polyomavirus integration as the primary oncogenic event in ~80% of Merkel cell carcinoma cases. The remaining virus-negative Merkel cell carcinoma cases associated with a high mutational load are most likely caused by UV radiation. The current study aimed to compare the morphological and immunohistochemical features of 80 virus-positive and 21 virus-negative Merkel cell carcinoma cases. Microscopic evaluation revealed that elongated nuclei-similar to the spindle-shape variant of small cell lung cancer-were less frequent in Merkel cell polyomavirus-positive Merkel cell carcinoma compared to the virus-negative subset (p = 0.005). Moreover, virus-negative cases more frequently displayed a "large-cell neuroendocrine carcinoma" phenotype with larger cell size (p = 0.0026), abundant cytoplasm (p = 4×10

Identifiants

pubmed: 31201352
doi: 10.1038/s41379-019-0288-7
pii: S0893-3952(22)00984-X
doi:

Substances chimiques

12E7 Antigen 0
Biomarkers, Tumor 0
CD99 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1605-1616

Auteurs

Thibault Kervarrec (T)

Department of Pathology, Université François Rabelais de Tours, CHU de Tours, avenue de la République, 37170, Chambray-les-tours, France. thibaultkervarrec@yahoo.fr.
Biologie des infections à polyomavirus team, UMR INRA ISP 1282, Université François Rabelais de Tours, 31, avenue Monge, 37200, Tours, France. thibaultkervarrec@yahoo.fr.
Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany. thibaultkervarrec@yahoo.fr.

Anne Tallet (A)

Platform of Somatic Tumor Molecular Genetics, Université François Rabelais de Tours, CHU de Tours, avenue de la République, 37170, Chambray-les-tours, France.

Elodie Miquelestorena-Standley (E)

Department of Pathology, Université François Rabelais de Tours, CHU de Tours, avenue de la République, 37170, Chambray-les-tours, France.

Roland Houben (R)

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany.

David Schrama (D)

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany.

Thilo Gambichler (T)

Department of Dermatology, Venereology and Allergology, University Hospital Bochum, GudrunStraße 5, 44791, Bochum, Germany.

Patricia Berthon (P)

Biologie des infections à polyomavirus team, UMR INRA ISP 1282, Université François Rabelais de Tours, 31, avenue Monge, 37200, Tours, France.

Yannick Le Corre (Y)

Dermatology Department, LUNAM Université, CHU Angers, 4 rue Larrey, 49933, Angers, France.

Ewa Hainaut-Wierzbicka (E)

Dermatology Department, Université de Poitiers, CHU de Poitiers, 2 rue de la Milétrie, 86021, Poitiers, France.

Francois Aubin (F)

Dermatology Department, Université de Franche Comté, CHU Besançon, EA3181, IFR133, 2 boulevard Fleming, 25030, Besançon, France.

Guido Bens (G)

Dermatology Department, CHR d'Orléans, 14 avenue de l'Hôpital, 45100, Orléans, France.

Flore Tabareau-Delalande (F)

Department of Pathology, CHR d'Orléans, 14 avenue de l'Hôpital, 45100, Orléans, France.

Nathalie Beneton (N)

Dermatology Department, CHR Le Mans, 194 avenue Rubillard, 72037, Le Mans Cedex 09, France.

Gaëlle Fromont (G)

Department of Pathology, Université François Rabelais de Tours, CHU de Tours, Boulevard Tonnellé, 37044, Tours, France.

Flavie Arbion (F)

Department of Pathology, Université François Rabelais de Tours, CHU de Tours, Boulevard Tonnellé, 37044, Tours, France.

Emmanuelle Leteurtre (E)

Univ. Lille, Inserm, CHU Lille, UMR-S 1172-JPARC-Jean-Pierre Aubert Research Center, F-59000, Lille, France.

Michael Herfs (M)

Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, 4000, Liege, Belgium.

Antoine Touzé (A)

Biologie des infections à polyomavirus team, UMR INRA ISP 1282, Université François Rabelais de Tours, 31, avenue Monge, 37200, Tours, France.

Mahtab Samimi (M)

Biologie des infections à polyomavirus team, UMR INRA ISP 1282, Université François Rabelais de Tours, 31, avenue Monge, 37200, Tours, France.
Dermatology Department, Université Francois Rabelais, CHU de Tours, avenue de la République, 37170, Chambray-les-tours, France.

Serge Guyétant (S)

Department of Pathology, Université François Rabelais de Tours, CHU de Tours, avenue de la République, 37170, Chambray-les-tours, France.
Biologie des infections à polyomavirus team, UMR INRA ISP 1282, Université François Rabelais de Tours, 31, avenue Monge, 37200, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH